Real-World safety and effectiveness of evolocumab in primary hypercholesterolemia and mixed dyslipidemia in Saudi Arabia

• Main Authors: Abdulaali R. Almutairi (Author), Walaa A. Alshahrani (Author), Ghaida K. Alhathlol (Author), Fatimah Alsheikh (Author), Abdulaziz Alakeel (Author), Majed S. Al Yami (Author), Mohammad Fouda (Author), Omar A. Almohammed (Author), Meshal S. Alhamed (Author), Awatif Hafiz (Author), Hussam Kutbi (Author), Alaa Bagalagel (Author), Aisha Alharbi (Author), Mashael Alaboud (Author), Sarah Aljohani (Author), Waddah Ashram (Author)
• Format: Book
• Published: Elsevier, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Evolocumab's short-term efficacy and safety were proven in phase-3 clinical trial, but its long-term safety and effectiveness in the Saudi population are yet to be studied. The aim of this study was to assess the long-term safety and effectiveness of evolocumab in Saudi patients w...